Evidence map›Paper›PMID 15504257›Full record

ReviewEmerging infectious diseases2004

Strain typing methods and molecular epidemiology of Pneumocystis pneumonia.

Charles Ben Beard, Patricia Roux, Gilles Nevez, Philippe M Hauser, Joseph A Kovacs, Thomas R Unnasch, Bettina Lundgren

Abstract readReview
In one paragraph

Review in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Multi-site screening forFrontiers in cellular and infection microbiology · 2026
    Article
  2. Molecular Study ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molecular techniques and the true content of reality.Emerging infectious diseases · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Charles Ben BeardDivision of Vector-Borne Infectious Disease, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA. cbeard@cdc.gov
Patricia Roux
Gilles Nevez
Philippe M Hauser
Joseph A Kovacs
Thomas R Unnasch
Bettina Lundgren

Funding

The Characterization of Pneumocystis Surface AntigensZ01CL000037 · CLC · CLINICAL CENTER · PI KOVACS, JOSEPH A · 1990 to 2008
$170k
The Characterization of Pneumocystis Surface AntigensZIACL000037 · CLC · CLINICAL CENTER · PI KOVACS, JOSEPH A · 2009 to 2018
$0k
6 · The paper itself

Abstract

Pneumocystis pneumonia (PCP) caused by the opportunistic fungal agent Pneumocystis jirovecii (formerly P. carinii) continues to cause illness and death in HIV-infected patients. In the absence of a culture system to isolate and maintain live organisms, efforts to type and characterize the organism have relied on polymerase chain reaction-based approaches. Studies using these methods have improved understanding of PCP epidemiology, shedding light on sources of infection, transmission patterns, and potential emergence of antimicrobial resistance. One concern, however, is the lack of guidance regarding the appropriateness of different methods and standardization of these methods, which would facilitate comparing results reported by different laboratories.

Indexed as

DNA, FungalHumansMembrane GlycoproteinsMolecular EpidemiologyMycological Typing TechniquesPneumocystis cariniiPneumonia, PneumocystisPolymorphism, GeneticReproducibility of ResultsRNA, FungalSensitivity and SpecificityDNA, FungalMembrane GlycoproteinsRNA, Fungal

Identifiers

PMID15504257
PMCPMC3323257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.